Evidence map›Paper›PMID 42680911›Full record

ArticleInternational urology and nephrology2026

Machine learning models for early detection of urinary tract infections in kidney transplant patients.

Alejandro Camargo-Salamanca, Liceth Viviana Castañeda-Silva, Carlos Puentes-Morales, Alejandro Duitama-Leal, Andrés Cardona-Mendoza, Alejandro Ramos-Casallas, Sandra J Perdomo, Consuelo Romero-Sánchez, Julia Andrea Gomez-Montero, Andrea Garcia-Lopez and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Alejandro Camargo-SalamancaNephrology Department, Colombiana de Trasplantes, Av. Carrera 30 # 47 A - 47., Bogotá DC, Colombia.ORCID http://orcid.org/0000-0002-4457-014X
Liceth Viviana Castañeda-SilvaVirtualization and Artificial Intelligence Advanced Solutions Laboratory (SavIA-Lab), Universidad El Bosque, Bogotá, Colombia.ORCID http://orcid.org/0009-0000-3292-7108
Carlos Puentes-MoralesVirtualization and Artificial Intelligence Advanced Solutions Laboratory (SavIA-Lab), SIGNOS Group, Science Faculty, Universidad El Bosque, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-7893-0668
Alejandro Duitama-LealVirtualization and Artificial Intelligence Advanced Solutions Laboratory (SavIA-Lab), SIGNOS Group, Science Faculty, Universidad El Bosque, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-5477-2191
Andrés Cardona-MendozaVirtualization and Artificial Intelligence Advanced Solutions Laboratory (SavIA-Lab), Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-6697-5471
Alejandro Ramos-CasallasVirtualization and Artificial Intelligence Advanced Solutions Laboratory (SavIA-Lab), Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-8742-7845
Sandra J PerdomoVirtualization and Artificial Intelligence Advanced Solutions Laboratory (SavIA-Lab), Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogotá, Colombia.ORCID http://orcid.org/0000-0001-7740-8141
Consuelo Romero-SánchezVirtualization and Artificial Intelligence Advanced Solutions Laboratory (SavIA-Lab), Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-6973-7639
Julia Andrea Gomez-MonteroResearch Department, Colombiana de Trasplantes, Bogotá, Colombia.ORCID http://orcid.org/0000-0001-6220-500X
Andrea Garcia-LopezResearch Department, Colombiana de Trasplantes, Bogotá, Colombia. aegarcia@colombianadetrasplantes.com.ORCID https://orcid.org/0000-0002-3940-1413
Fernando Girón-LuqueResearch Department, Colombiana de Trasplantes, Bogotá, Colombia.ORCID http://orcid.org/0000-0001-6307-0848

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal transplantation is the preferred treatment for end-stage chronic kidney disease but requires lifelong immunosuppression, increasing the risk of infections such as urinary tract infection (UTI). UTI in kidney transplant recipients can lead to serious complications, including acute kidney injury, reduced graft survival, and increased mortality. Machine learning can enhance risk detection accuracy and support proactive management of complications. This study aims to develop a machine learning-based approach for predicting urinary tract infections in kidney transplant recipients, facilitating the early identification of high-risk individuals.

methodsRetrospective cohort of 29,340 anonymized records from a Colombian transplant center to develop and compare machine learning models for predicting UTI in post-kidney transplant patients. Fifteen machine learning models were evaluated using 41 sociodemographic and clinical variables. Model performance was assessed using metrics such as accuracy and area under the ROC curve (AUC).

resultsBoth models are good, with Random Forest achieving 93.57% accuracy, 94.43% AUC, 92.5% sensitivity, and 95.2% specificity. XGBoost achieved 91.14% accuracy, 91.65% AUC, 90.8% sensitivity, and 92.6% specificity. Feature importance analysis revealed that key predictors included Body mass index (BMI), use of mofetil mycophenolate or sodium mycophenolate, donor type, hypertension, diabetes mellitus, use of steroids, re-transplantation, serum levels of tacrolimus and sex of the recipient.

conclusionThis study demonstrates the potential of machine learning models to predict UTI in kidney transplant patients, offering a tool for early intervention and personalized care. Implementing these models in clinical settings could improve patient outcomes and reduce healthcare costs by preventing severe complications associated.

Indexed as

Kidney transplantMachine learningPredictive value of testsRisk factorsUrinary tract infection

Identifiers

PMID42680911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.